Literature DB >> 14704120

Effects of dl-praeruptorin A on nucleus factor-kappaB and tumor necrosis factor-alpha expression in ischemia-reperfusion hearts.

Chi Wang1, Tian-Hui Chang, Xin-Hua Zhang, Huai-Liang Wang.   

Abstract

AIM: To study the effects of dl-praeruptorin A (Pd-Ia) on nucleus factor-kappaB (NF-kappaB) activativity and tumor necrosis factor-alpha (TNF-alpha) expression in ischemia-reperfusion (I/R) myocardium.
METHODS: Langendorff's isolated rat heart was subjected to a 10-min ischemia followed by a 30-min reperfusion. NF-kappaB activity in nucleus was analyzed by Sandwich Enzyme-Linked Immunosorbent Assay (ELISA). TNF-alpha level in cytoplasm was measured by radioimmunoassay. Infiltration of neutrophils was observed using Hematoxylin-Eosin staining under optical microscope.
RESULTS: Pd-Ia 1.0 micromol/L with 30-min preventive perfusion decreased NF-kappaB activity from 0.98+/-0.13 to 0.65+/-0.17 (P<0.05 vs solvent) and down-regulated TNF-alpha expression from 13.7+/-6.1 microg/L to 9.4+/-2.7 microg/L (P<0.01 vs solvent) under conditions with increase of coronary flow, negative inotropic action, inhibition of creatine kinase and without chronotropic action, whereas, infiltration of neutrophils was mild.
CONCLUSION: Pd-Ia inhibited NF-kappaB activativity in I/R myocardium and led to down-regulation of TNF-alpha expression, which might be one of molecular mechanisms of Pd-Ia in cardioprotection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704120

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  2 in total

1.  Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis.

Authors:  Z Zhang; Xf Liang; Mq Su; Q Liang; Lp Li; Xh Zhang; Xm Wang; X Zhu
Journal:  Daru       Date:  2011       Impact factor: 3.117

Review 2.  Biological activities and pharmacokinetics of praeruptorins from Peucedanum species: a systematic review.

Authors:  Parisa Sarkhail; Abbas Shafiee; Pantea Sarkheil
Journal:  Biomed Res Int       Date:  2013-11-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.